Clinical Trial Update: Submucosal Dexamethasone for Control of Post-operative Pain, Trismus, and Swelling After Mandibular Third Molar Surgery [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating submucosal dexamethasone to control postoperative pain, trismus, and swelling after mandibular third molar extraction has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Impacted Mandibular Third Molar Extraction

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)

Snippet

Sponsor: PAEC General Hospital, Islamabad | Conditions: Impacted Mandibular Third Molar Extraction | Phase 4 | Status: COMPLETED